Peripheral natural killer cells and myeloid-derived suppressor cells correlate with anti-PD-1 responses in non-small cell lung cancer

Inhibition of immune checkpoint proteins like programmed death 1 (PD-1) is a promising therapeutic approach for several cancers, including non-small cell lung cancer (NSCLC). Although PD-1 ligand (PD-L1) expression is used to predict anti-PD-1 therapy responses in NSCLC, its accuracy is relatively l...

Descripción completa

Detalles Bibliográficos
Autores principales: Youn, Je-In, Park, Su-Myeong, Park, Seyeon, Kim, Gamin, Lee, Hee-Jae, Son, Jimin, Hong, Min Hee, Ghaderpour, Aziz, Baik, Bumseo, Islam, Jahirul, Choi, Ji-Woong, Lee, Eun-Young, Kim, Hang-Rae, Seo, Sang-Uk, Paik, Soonmyung, Yoon, Hong In, Jung, Inkyung, Xin, Chun-Feng, Jin, Hyun-Tak, Cho, Byoung Chul, Seong, Seung-Yong, Ha, Sang-Jun, Kim, Hye Ryun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7270107/
https://www.ncbi.nlm.nih.gov/pubmed/32493990
http://dx.doi.org/10.1038/s41598-020-65666-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7270107/
https://www.ncbi.nlm.nih.gov/pubmed/32493990
http://dx.doi.org/10.1038/s41598-020-65666-x

Ejemplares similares